much
evid
support
notion
angiotensin
ii
ang
ii
central
product
reninangiotensin
system
ra
may
play
central
role
etiolog
hypertens
also
pathophysiolog
cardiovascular
diseas
human
ang
ii
via
ang
ii
type
receptor
directli
caus
cellular
phenotyp
chang
cell
growth
regul
gene
express
variou
bioactiv
substanc
activ
multipl
intracellular
signal
cascad
cardiac
myocyt
fibroblast
well
vascular
endotheli
smooth
muscl
cell
recent
new
factor
discov
angiotensinconvert
enzym
angiotensin
receptor
ma
section
summar
current
knowledg
broad
ra
pathophysiolog
cardiac
hypertrophi
remodel
heart
failur
vascular
thicken
atherosclerosi
handbook
biolog
activ
peptid
http
dx
research
reninangiotensin
system
ra
began
discoveri
renin
kidney
tiegerstedt
bergman
peptid
vasoconstrict
effect
ra
discov
name
hypertensin
braunmenendez
argentina
angionin
page
helmer
unit
state
two
term
persist
year
agre
renam
pressor
substanc
angiotensin
two
form
angiotensin
recogn
first
decapeptid
angiotensin
ang
second
octapeptid
angiotensin
ii
ang
ii
skegg
et
al
unit
state
report
ang
ii
form
enzymat
cleavag
ang
anoth
enzym
term
angiotensinconvert
enzym
ace
schwyzer
bumpu
succeed
synthesi
ang
ii
gross
suggest
ra
involv
regul
aldosteron
secret
davi
genet
laragh
et
al
prove
hypothesi
earli
polypeptid
either
inhibit
format
ang
ii
block
ang
ii
receptor
discov
oral
activ
cushman
ondetti
succeed
develop
captopril
oral
activ
ace
inhibitor
mani
experiment
clinic
studi
ace
inhibitor
uncov
addit
role
ra
pathophysiolog
hypertens
heart
failur
vascular
diseas
furthermor
losartan
dup
oral
activ
highli
select
potent
nonpeptid
ang
ii
receptor
blocker
arb
develop
clone
ang
ii
receptor
type
r
type
r
accomplish
earli
angiotensin
ang
discov
santo
et
al
angiotensinconvert
enzym
identifi
catalyz
convers
ang
ang
ang
remov
singl
carboxytermin
amino
acid
essenti
regul
heart
function
function
receptor
sar
coronaviru
ra
play
import
role
regul
arteri
blood
pressur
renin
enzym
act
angiotensinogen
catalyz
format
ang
ang
cleav
ace
yield
ang
ii
represent
biochem
pathway
ra
shown
fig
major
element
rate
ang
ii
product
amount
renin
releas
kidney
renin
synthes
store
secret
renal
arteri
circul
granular
juxtaglomerular
cell
secret
renin
control
predominantli
three
pathway
first
mechan
control
renin
releas
intraren
macula
densa
pathway
second
intraren
baroreceptor
pathway
third
mechan
receptor
pathway
mediat
releas
norepinephrin
postganglion
sympathet
nerv
termin
increas
renin
secret
enhanc
format
ang
ii
ang
ii
stimul
r
juxtaglomerular
cell
inhibit
renin
releas
substrat
renin
angiotensinogen
abund
globulin
circul
plasma
primari
structur
angiotensinogen
deduc
molecular
clone
angiotensinogen
synthes
primarili
liver
although
mrna
encod
protein
abund
fat
certain
region
central
nervou
system
kidney
rate
ang
ii
synthesi
influenc
chang
angiotensinogen
level
ace
discov
plasma
factor
respons
convers
ang
ang
ii
ace
gene
contain
intron
insertiondelet
polymorph
explain
phenotyp
varianc
serum
ace
level
individu
homozyg
delet
allel
higher
level
serum
ace
ang
rapidli
convert
ang
ii
given
intraven
ang
iii
ang
form
action
aminopeptidas
ang
ii
ang
iii
ang
ii
caus
qualit
similar
effect
ang
iii
approxim
potent
ang
ii
stimul
secret
aldosteron
howev
ang
iii
potent
ang
ii
elev
blood
pressur
ang
iv
ang
gener
sequenti
cleavag
two
amino
acid
residu
amino
terminu
ang
ii
aminopeptidas
local
endotheli
surfac
bypass
pathway
ra
produc
ang
ii
besid
main
enzym
renin
ace
arakawa
et
al
show
trypsin
kallikrein
produc
ang
ii
one
famou
enzym
bypass
pathway
heart
chymas
secret
mast
cell
circul
renin
renal
origin
act
circul
angiotensinogen
hepat
origin
produc
ang
plasma
circul
ang
convert
plasma
ace
pulmonari
endotheli
ace
ang
ii
ang
ii
deliv
target
organ
via
blood
flow
tradit
pathway
call
circul
ra
howev
heart
blood
vessel
sever
tissu
contain
andor
synthes
compon
ra
call
tissu
local
ra
mani
tissu
includ
heart
blood
vessel
brain
kidney
adren
gland
express
mrna
renin
angiotensinogen
andor
ace
furthermor
sever
ang
cleavag
product
found
cultur
cell
type
tissu
exampl
ang
ang
ang
iii
ang
iv
fig
ang
ang
ii
local
atria
ventricl
therefor
seem
tissu
ra
exist
independ
renalhepaticbas
system
sever
serin
proteas
tonin
cathepsin
g
shown
hydrolyz
ang
ii
precursor
aspartyl
proteas
cathepsin
dlike
properti
shown
convert
angiotensinogen
ang
convers
ang
ang
ii
human
dog
cardiac
ventricl
may
occur
heart
chymas
unlik
ace
human
heart
chymas
show
high
specif
ang
degrad
bradykinin
vasoact
intestin
peptid
like
rel
contribut
ace
chymas
cardiac
ang
ii
format
vari
cardiac
chamber
human
heart
ace
level
highest
atria
chymas
level
highest
ventricl
recent
believ
chymas
play
crucial
role
variou
tissu
chymas
produc
ang
ii
also
convert
precursor
transform
growth
factor
tgf
matrix
activ
form
whose
increas
damag
variou
organ
effect
angiotensin
exert
specif
cell
surfac
receptor
two
subtyp
ang
ii
receptor
type
r
r
success
clone
r
r
allow
develop
research
structur
function
receptor
r
consist
two
subtyp
r
r
homolog
regard
amino
acid
sequenc
similar
pharmacolog
properti
tissu
distribut
pattern
r
member
seventransmembranespan
g
proteincoupl
receptor
gpcr
famili
bind
heterotrimer
g
protein
lack
intrins
tyrosin
kinas
activ
human
r
gene
map
chromosom
r
r
gene
rat
map
chromosom
respect
r
ubiquit
abundantli
distribut
adult
tissu
includ
blood
vessel
heart
kidney
adren
gland
liver
brain
lung
r
mediat
classic
wellknown
effect
ang
ii
elev
blood
pressur
vasoconstrict
increas
cardiac
contractil
aldosteron
releas
adren
gland
facilit
catecholamin
releas
nerv
end
renal
sodium
water
absorpt
therefor
r
role
atherosclerosi
congest
cardiac
failur
sever
acut
chronic
inflammatori
diseas
condit
inflamm
known
play
signific
role
fig
numer
select
potent
nonpeptid
r
antagonist
losartan
candesartan
valsartan
irbesartan
eprosartan
telmisartan
tasosartan
develop
contrast
r
high
affin
cdna
genom
dna
human
rat
mous
rs
clone
r
mainli
express
develop
fetal
tissu
believ
essenti
role
physiolog
vascular
develop
r
express
rapidli
decreas
birth
adult
express
receptor
limit
mainli
uteru
ovari
certain
brain
nuclei
heart
adren
medulla
unlik
r
shown
subtyp
rat
mice
evid
subtyp
r
although
comparison
amino
acid
sequenc
r
r
rat
deduc
nucleotid
sequenc
show
low
homolog
receptor
r
also
seventransmembran
domain
receptor
variou
cell
line
ractiv
protein
tyrosin
phosphatas
shown
inhibit
cell
growth
induc
program
cell
death
apoptosi
r
inhibit
rmediat
cell
growth
demonstr
antagonist
action
believ
express
balanc
import
cardiovascular
diseas
also
conflict
find
regard
receptor
exampl
controversi
whether
cardiac
hypertrophi
promot
r
howev
r
play
cardioprotect
role
left
ventricular
function
myocardi
infarct
contrast
extens
data
molecular
cellular
function
pathophysiolog
signific
r
role
r
cardiovascular
diseas
remain
defin
present
implic
overstimul
r
longterm
use
arb
investig
clinic
trial
suggest
ang
mediat
effect
interact
gpcr
ma
prototyp
seventransmembran
domain
receptor
predominantli
express
brain
testi
also
found
kidney
heart
blood
vessel
ang
receptor
origin
defin
specif
highaffin
bind
site
ang
iv
therefor
suspect
classic
gpcr
albiston
et
al
identifi
transmembran
enzym
insulinregul
aminopeptidas
irap
abund
protein
found
special
vesicl
contain
insulinsensit
glucos
transport
gener
patholog
left
ventricular
hypertrophi
character
increas
myocyt
size
quantit
chang
also
myocyt
gene
reprogram
qualit
chang
shown
enhanc
express
fetal
phenotyp
gene
heavi
chain
skelet
atrial
natriuret
peptid
anp
cardiac
ventricl
mammalian
speci
mhc
consist
two
isoform
rat
predomin
isoform
adult
heart
wherea
predomin
isoform
fetal
heart
therefor
chang
ratio
cardiac
ventricl
significantli
alter
contractil
properti
heart
cardiac
sarcomer
actin
also
compos
two
isoform
cardiac
skelet
cardiac
predominantli
express
adult
rat
heart
wherea
skelet
normal
express
fetal
neonat
rat
heart
ratio
skelet
cardiac
ventricl
play
signific
role
cardiac
function
skelet
greater
contractil
cardiac
furthermor
addit
show
enhanc
express
skelet
hypertroph
ventricular
myocyt
also
character
signific
upregul
anp
scarc
express
normal
adult
ventricular
myocyt
anoth
import
properti
patholog
cardiac
hypertrophi
increas
accumul
extracellular
matrix
ecm
protein
collagen
particularli
collagen
type
iii
fibronectin
interstitium
around
blood
vessel
within
heart
chang
play
central
role
ventricular
fibrosi
remodel
increas
interstiti
collagen
deposit
heart
enhanc
cardiac
stiff
result
diastol
dysfunct
fibronectin
local
surfac
cardiac
myocyt
connect
cardiac
myocyt
perimyocyt
collagen
believ
affect
cardiac
systol
diastol
function
thu
increas
ecm
accumul
abovement
ventricular
myocyt
gene
reprogram
play
critic
role
impair
cardiac
perform
pathophysiolog
cardiac
failur
ecm
protein
within
heart
predominantli
produc
fibroblast
unlik
cardiac
myocyt
cardiac
fibroblast
prolifer
increas
product
ecm
protein
heart
expos
hypertroph
stimuli
hemodynam
overload
thu
cardiac
fibroblast
cardiac
myocyt
play
key
role
develop
patholog
cardiac
hypertrophi
dysfunct
accumul
vitro
vivo
evid
support
concept
ang
ii
involv
import
process
patholog
cardiac
hypertrophi
includ
myocyt
hypertrophi
myocyt
gene
reprogram
fibroblast
prolifer
ecm
protein
accumul
effect
r
cardiac
remodel
fig
activ
r
activ
multipl
signal
pathway
acut
vasoconstrictor
function
ang
ii
primarili
mediat
r
classic
g
proteindepend
signal
mechan
investig
effect
ang
ii
cardiac
intracellular
signal
cascad
essenti
elucid
molecular
mechan
underli
ang
iiinduc
patholog
cardiac
hypertrophi
accumul
vitro
evid
cultur
cardiac
myocyt
fibroblast
suggest
mitogenactiv
protein
map
kinas
includ
extracellular
signalregul
kinas
erk
cjun
amino
termin
kinas
jnk
kinas
may
respons
myocyt
hypertrophi
gene
reprogram
fibroblast
prolifer
ang
iiinduc
cardiac
activ
jnk
occur
sensit
manner
erk
erk
cascad
activ
plateletderiv
growth
factor
pdgf
epiderm
growth
factor
receptor
egfr
insulin
receptor
pathway
nonreceptor
tyrosin
kinas
belong
csrc
famili
prolinerich
tyrosin
kinas
focal
adhes
kinas
janu
kinas
jak
besid
g
proteindepend
effect
ang
ii
activ
r
activ
r
also
stimul
g
proteinindepend
signal
transduct
mechan
directli
associ
signal
molecul
jak
src
jnk
activ
ang
ii
without
erk
activ
follow
activ
activ
importantli
regul
express
variou
gene
bind
consensu
sequenc
present
promot
region
interestingli
fetal
phenotyp
cardiac
gene
skelet
anp
cardiac
fibrosisassoci
gene
collagen
type
respons
sequenc
promot
region
inde
activ
demonstr
lead
increas
promot
activ
skelet
therefor
intrigu
postul
jnk
activ
part
activ
may
implic
ang
iiinduc
cardiac
hypertroph
respons
vivo
vivo
studi
show
apoptosi
signalregul
kinas
one
map
kinas
kinas
kinas
play
import
role
ang
iiinduc
cardiac
hypertrophi
remodel
includ
cardiomyocyt
hypertrophi
cardiac
hypertrophyrel
mrna
upregul
cardiomyocyt
apoptosi
interstiti
fibrosi
coronari
arteri
remodel
collagen
gene
upregul
ra
system
network
mediat
myocardi
remodel
mrna
protein
express
augment
cardiomyocyt
cardiac
fibroblast
situat
transdifferenti
myofibroblast
phenotyp
follow
progress
diastol
dysfunct
ang
ii
caus
signific
increas
mrna
chronic
administr
ang
iiinduc
protein
express
myocardium
ang
iiinduc
hypertroph
growth
cardiomyocyt
mediat
downstream
ang
ii
network
mice
express
constitut
hyperact
chronic
hypertrophi
fibrosi
cardiac
dysfunct
resist
arb
telmisartan
block
antagonist
ang
iimedi
cardiac
remodel
mechan
thu
depend
studi
perform
far
clear
ang
induc
autocrineparacrin
cellular
respons
cardiac
fibroblast
myocardi
interstitium
cardiomyocyt
caus
cardiac
hypertrophi
ang
iiinduc
signal
also
induc
transloc
smad
protein
nucleu
drive
transcript
fibrot
marker
protein
collagen
fibronectin
connect
tissu
growth
factor
ctgf
ctgf
profibrot
factor
stimul
respons
mediat
fibrosi
apoptosi
inflammatori
cytokin
vascular
cell
adhes
monocyt
chemoattract
believ
import
role
coupl
acut
ischem
episod
chronic
myocardi
remodel
chronic
angiotensin
receptor
stimul
ang
ii
facilit
releas
norepinephrin
cardiac
sympathet
nerv
termin
ang
iiinfus
rat
surgic
cardiac
sympathectomi
treatment
adrenerg
receptor
blocker
significantli
prevent
cardiac
myocyt
necrosi
show
ang
iiinduc
cardiac
damag
least
part
mediat
catecholamin
releas
cardiac
sympathet
neuron
thu
activ
cardiac
sympathet
neuron
ang
ii
also
contribut
patholog
cardiac
hypertrophi
ang
ii
via
r
also
known
potent
mediat
oxid
stress
reactiv
oxygen
speci
ro
mediat
signal
larg
bodi
evid
indic
ro
play
major
part
initi
progress
cardiovascular
dysfunct
associ
diseas
hyperlipidemia
diabet
mellitu
hypertens
ischem
heart
diseas
chronic
heart
failur
addit
ang
ii
signal
activ
membran
nad
p
h
oxidas
vsmc
produc
ro
mediat
pleiotroph
effect
ang
ii
ang
ii
signal
mediat
activ
nad
p
h
oxidas
involv
upstream
mediat
src
phosphoryl
transcript
factor
nuclear
implic
pathogenesi
atherosclerosi
activ
ro
ro
may
caus
vessel
inflamm
induc
releas
cytokin
caus
increas
express
leukocyt
adhes
molecul
cell
membran
may
increas
recruit
monocyt
area
endotheli
damag
thu
activ
rinduc
ro
product
lead
chang
structur
function
properti
vasculatur
central
aspect
vascular
pathobiolog
hypertens
diabet
cardiovascular
diseas
numer
vivo
experi
shown
ang
ii
induc
vsmc
prolifer
vivo
ang
ii
infus
increas
mesenter
vascular
media
width
media
crosssect
area
medialumen
ratio
despit
detail
investig
molecular
mechan
ang
iimedi
vsmc
growth
vitro
process
poorli
understood
ang
ii
infus
least
part
independ
blood
pressureelev
effect
increas
aortic
mrna
protein
express
fibronectin
ecm
protein
induc
phenotyp
chang
vsmc
contractil
synthet
phenotyp
basic
fibroblast
growth
factor
bfgf
may
play
key
role
ang
iimedi
vsmc
replic
vivo
shown
observ
inject
antibfgf
antibodi
significantli
inhibit
mitogen
effect
ang
ii
infus
rat
carotid
arteri
ang
ii
infus
rat
doubl
superoxid
product
rat
aorta
activ
nad
p
h
oxidas
hand
norepinephrin
infus
increas
vascular
superoxid
product
despit
hypertens
effect
compar
ang
ii
suggest
vsmc
growth
due
ang
ii
may
specif
mediat
increas
superoxid
gener
ang
ii
infus
rat
increas
heme
mrna
protein
endothelium
oxidantsensit
gene
possibl
increas
oxid
stress
trigger
mrna
upregul
ang
iiinfus
rat
aorta
may
serv
abrog
increas
stress
caus
ang
ii
ang
ii
infus
stimul
aortic
thrombin
receptor
mrna
express
rat
block
either
arb
heparinbind
chimera
human
cuzn
superoxid
dismutas
normal
blood
pressur
hydralazin
treatment
suggest
ang
ii
increas
vascular
thrombin
receptor
rmediat
superoxid
product
may
implic
pathophysiolog
atherosclerosi
thrombin
cascad
activ
inject
ang
ii
result
increas
oxid
lowdens
lipoprotein
uptak
periton
macrophag
increas
macrophag
proteoglycan
content
suggest
ang
ii
may
acceler
atherosclerosi
promot
foam
cell
format
cholesterol
accumul
vascular
wall
endotheli
dysfunct
context
hypertens
cardiovascular
diseas
partli
depend
product
ro
rinduc
ro
burn
nitric
oxid
also
reduc
format
endothelium
oxid
tetrahydrobiopterin
crucial
cofactor
endotheli
synthas
eno
superoxid
anion
highli
reactiv
ro
known
caus
breakdown
endothelialderiv
relax
factor
dysfunct
endothelium
regener
endothelium
impair
abil
releas
endothelialderiv
relax
factor
particular
activ
angiotensin
receptor
trigger
efflux
cytosol
calcium
endotheli
cell
ec
calcium
efflux
activ
releas
arachidon
acid
metabol
cyclooxygenas
cox
gener
variou
eicosanoid
includ
endoperoxid
variou
prostaglandin
activ
thromboxan
receptor
locat
vsmc
caus
contract
endotheli
cox
activ
also
produc
ro
addit
uric
acid
despit
known
antioxid
effect
may
caus
human
vascular
ec
dysfunct
local
activ
ra
induc
oxid
stress
ro
may
turn
activ
local
ra
whole
vasculatur
includ
ec
smooth
muscl
cell
fibroblastenhanc
ang
ii
product
concomit
stimul
r
creat
posit
feedback
loop
local
ra
ro
thu
hypertens
cardiovascular
diseas
endotheli
dysfunct
character
blunt
endotheliumdepend
vasodil
enhanc
endotheliumdepend
contract
gener
r
believ
promot
apoptosi
inhibit
prolifer
hypertrophi
unlik
r
r
contribut
mainten
blood
pressur
control
vascular
tone
vasodilat
avail
evid
indic
link
r
bradykinin
b
receptor
b
r
product
vasodil
r
stimul
ang
ii
lead
increas
cgmp
level
mechan
involv
b
r
caus
releas
r
activ
stimul
bradykinin
format
activ
kininogenas
chronic
infus
ang
ii
r
overexpress
mice
complet
abolish
rmediat
pressor
effect
suggest
vasodilat
r
block
one
inhibitor
b
r
no
addit
aortic
explant
transgen
mice
overexpress
r
show
greatli
increas
cgmpno
product
diminish
rinduc
vascular
constrict
remov
endothelium
treatment
inhibitor
b
r
no
abolish
rmediat
effect
indic
endothelium
primari
site
effect
manifest
r
r
aortic
smc
also
stimul
product
bradykinin
stimul
nocgmp
system
promot
vasodil
rdefici
mice
bradykinininduc
dilat
serious
impair
bradykinininduc
dilat
inhibit
r
antagonist
losartan
arb
thu
r
b
r
may
form
function
heterodim
recent
shown
might
lead
increas
cgmp
product
physic
associ
dimer
r
b
r
initi
chang
intracellular
phosphoprotein
signal
activ
enhanc
product
cgmp
growth
apoptosi
also
two
opposit
compon
tissu
remodel
cardiac
remodel
happen
certain
physiolog
patholog
circumst
exercis
age
hypertens
myocardi
infarct
known
although
r
express
decreas
sharpli
birth
increas
pathophysiolog
condit
stimul
r
express
may
inhibit
neointima
format
cell
prolifer
inflamm
vascular
injuri
myocardi
infarct
ischem
diseas
suggest
protect
role
convers
rdefici
mice
recoveri
acut
myocardi
infarct
reduc
compar
wildtyp
mice
although
neointima
format
vsmc
prolifer
vascular
injuri
exagger
rdefici
mice
suppress
rdefici
mice
r
possibl
exert
antiprolif
effect
proapoptot
effect
vsmc
control
r
number
apoptot
cell
injur
arteri
increas
significantli
rdefici
mice
decreas
rdefici
mice
indic
r
mediat
apoptosi
select
r
stimul
also
inhibit
restenosi
balloon
angioplasti
thu
experiment
studi
shown
benefici
role
reexpress
r
vascular
injuri
lead
inhibit
cell
growth
promot
apoptosi
gene
transfer
studi
vivo
also
support
r
express
attenu
neointima
accumul
injur
carotid
arteri
antagon
growthpromot
effect
r
vascular
injuri
studi
use
mice
disrupt
r
express
show
enhanc
neointim
format
compar
wildtyp
mice
suggest
protect
role
r
r
express
upregul
sever
diseas
condit
left
ventriclespecif
r
overexpress
mice
elev
left
ventricular
endodiastol
pressur
increas
systol
diastol
dimens
sever
depress
left
ventricular
fraction
shorten
wall
thin
observ
suggest
ventricular
myocytespecif
express
r
promot
develop
dilat
cardiomyopathi
heart
failur
vivo
vivo
ectop
r
overexpress
postnat
left
ventricular
myocardium
thu
detriment
explain
sharp
declin
r
birth
prolong
arb
treatment
turn
complet
benefici
clinic
trial
either
dosag
effect
depend
time
site
r
express
implic
overstimul
r
longterm
use
arb
investig
clinic
trial
ang
mediat
effect
interact
grcr
ma
prototyp
seventransmembran
domain
receptor
predominantli
express
brain
testi
also
found
kidney
heart
blood
vessel
moreov
sever
studi
shown
interact
ang
ma
induc
protect
cardiovascular
action
releas
akt
phosphoryl
vasodil
ang
also
function
antithrombot
antiprolif
antioxid
agent
although
mechan
action
vascular
system
yet
well
establish
sever
studi
focus
control
balanc
regul
cardiovascular
function
reduct
superoxid
dismutas
catalas
activ
masdefici
mice
demonstr
impair
antioxid
properti
anim
moreov
ro
level
increas
masdefici
anim
masdefici
mice
exhibit
impair
vivo
endotheli
function
increas
blood
pressur
transgen
rat
overexpress
human
vsmc
show
improv
endotheli
function
decreas
vasoconstrict
respons
ang
ii
furthermor
infus
ave
ma
agonist
increas
hypotens
effect
bradykinin
rat
one
plausibl
mechan
effect
involv
increas
level
protect
endotheli
cell
ang
iimedi
macrophag
infiltr
oxid
stress
ang
depend
manner
atherosclerosi
longterm
ang
treatment
induc
atheroprotect
effect
apoedefici
mice
anim
model
atherosclerosi
improv
endotheli
function
result
increas
bioavail
heptapeptid
increas
no
express
decreas
product
genet
delet
significantli
increas
plaqu
format
apoedefici
mice
decreas
target
vascular
overexpress
consequ
action
ma
system
may
exploit
treatment
atherosclerosi
vascular
diseas
thu
ma
system
opposit
function
classic
ra
tissu
respons
blood
pressur
regul
cardiovascular
homeostasi
decreas
product
ro
increas
eno
improv
antioxid
capac
cardiovascular
tissu
ma
system
may
becom
import
therapeut
target
cardiovascular
protect
